On February 1, 2010, The Third General Assembly of the Ninth Chinese Pharmacopoeia Commission and the Summing-up Conference on Compilation of Chinese Pharmacopoeia (2010 Edition) was held in Beijing. Shao Mingli, Deputy Minister of Health, Commissioner of SFDA, and Chairman of the ninth Chinese Pharmacopoeia Commission attended the conference and delivered a speech.

Shao fully affirmed the achievements of the work on the compilation of Chinese Pharmacopoeia (2010 Edition), hoping all workers for drug standards to take the 2010 edition of Chinese Pharmacopoeia as a new start for their work, further improve the work of Chinese Pharmacopoeia and the elaboration and revisions of national drug standards, and realize new developments of the work on national drug standards. Efforts shall be made to establish and improve legal system for drug standards; continuously enhance the overall level of national drug standards; continue to optimize drug standard management mechanism; actively plan for the compilation of the 2015 edition of Chinese Pharmacopoeia; accelerate building a high-quality and comprehensive professional team.

2010 Chinese Pharmacopoeia, the 9th edition of the Pharmacopoeia of the People's Republic of China, contains a total of 4567 monographs, including 1386 new admissions; in Volume I, it contains 2165 monographs of Chinese materia medica and prepared slices of Chinese crude drugs, vegetable oil/ fats and extractives, traditional Chinese patent medicines and simple preparations, with 1019 new admissions, and 634 revisions; Volume II includes 2271 monographs of chemical drugs, antibiotics, biochemical preparations, radiopharmaceuticals and excipients, with 330 new admissions and 1500 revisions; Volume III contains 131 monographs of biological products, with 37 new admissions and 94 revisions; and there are 47 new admissions and 154 revisions in the Appendix.